Inhibiting AChE to restore acetylcholine levels is an effective treatment for senile dementia (such as Alzheimer’s disease, vascular dementia, Parkinson’s disease, or physical and cognitive symptoms associated with multiple sclerosis and Down syndrome). This evidence concerns the gene ACHE and early-onset autosomal dominant Alzheimer disease.